[HTML][HTML] Role of gambogic acid and NaI131 in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu… - Oncology …, 2017 - spandidos-publications.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
[HTML][HTML] Role of gambogic acid and NaI131 in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu… - Oncology …, 2017 - spandidos-publications.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and NaI131 in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu, Y Xie… - Oncology …, 2017 - search.proquest.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and NaI131 in A549/DDP cells.
J Huang, X Zhu, H Wang, S Han, L Liu, Y Xie… - Oncology …, 2016 - europepmc.org
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and NaI131 in A549/DDP cells.
J HUANG, X ZHU, H WANG, S HAN, LU LIU… - Oncology …, 2017 - search.ebscohost.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and NaI131 in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu… - Oncology …, 2017 - pubmed.ncbi.nlm.nih.gov
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
[HTML][HTML] Role of gambogic acid and NaI131 in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu, Y Xie… - Oncology …, 2017 - ncbi.nlm.nih.gov
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and Na [I. sup. 131] in A549/DDP cells
J Huang, X Zhu, H Wang, S Han, L Liu, Y Xie… - Oncology …, 2017 - go.gale.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
Role of gambogic acid and NaI131 in A549/DDP cells
J HUANG, X ZHU, H WANG, S HAN… - ONCOLOGY …, 2017 - ingentaconnect.com
Resistance to platinum in tumor tissue is a considerable barrier against effective lung cancer
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …
treatment. Radionuclide therapy is the primary adjuvant treatment, however, the toxic side …